Diencephalic involvement in generalized lipodystrophy: rationale and treatment with the neuroleptic agent, pimozide.
D000818:Animals; D002648:Child; D002746:Chlorpromazine / Q000494:pharmacology / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003346:Corticotropin-Releasing Hormone / Q000097:blood; D003864:Depression, Chemical; D004027:Diencephalon / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008060:Lipodystrophy / Q000188:drug therapy* / Q000378:metabolism; D008111:Liver Function Tests; D008297:Male; D010868:Pimozide / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D007328:Insulin; D008055:Lipids; D014280:Triglycerides; D010868:Pimozide; D007987:Gonadotropin-Releasing Hormone; D013006:Growth Hormone; D003346:Corticotropin-Releasing Hormone; D002784:Cholesterol; D002746:Chlorpromazine; D006854:Hydrocortisone